Bausch + Lomb Q4 rev $1.405B (+10%), net loss $58M; guides FY2026 rev $5.375B-$5.475B

Bausch & Lomb Corp

2025-FY EPS reported -$1.02 revenue$5,101,000,000

Q4 revenue $1.405B (+10% reported, +7% constant currency); FY revenue $5.101B (+6% reported, +5% constant currency).
Q4 GAAP net loss $58M (vs $3M loss in Q4 2024); FY net loss $360M (vs $317M).
Q4 adjusted EBITDA $326M (+$67M YoY); adjusted EPS $0.32 (vs $0.25). FY adjusted EBITDA $858M; adjusted EPS $0.43.
Segment: Vision Care $778M (+8%), Surgical $249M (+8%), Pharma $378M (+16%); MIEBO sales $112M in Q4.
FY2026 guidance: revenue $5.375B-$5.475B (5-7% constant currency growth); adjusted EBITDA ex-IPR&D $1.000B-$1.050B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.